| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acknowledgement to Reviewers 2010
|
|
|
2011
|
71 |
1 |
p. 119-121
3 p.
|
artikel
|
| 2 |
A multicenter phase II study to evaluate the efficacy and safety of gefitinib as first-line treatment for Korean patients with advanced pulmonary adenocarcinoma harboring EGFR mutations
|
Kim, Dong-Wan
|
|
2011
|
71 |
1 |
p. 65-69
5 p.
|
artikel
|
| 3 |
A phase I study of nimotuzumab in combination with radiotherapy in stages IIB–IV non-small cell lung cancer unsuitable for radical therapy: Korean results
|
Choi, Hye Jin
|
|
2011
|
71 |
1 |
p. 55-59
5 p.
|
artikel
|
| 4 |
A phase I study of S-1 with concurrent thoracic radiotherapy in elderly patients with localized advanced non-small cell lung cancer
|
Takigawa, Nagio
|
|
2011
|
71 |
1 |
p. 60-64
5 p.
|
artikel
|
| 5 |
Apolipoprotein E expression promotes lung adenocarcinoma proliferation and migration and as a potential survival marker in lung cancer
|
Su, Wen-Pin
|
|
2011
|
71 |
1 |
p. 28-33
6 p.
|
artikel
|
| 6 |
A qualitative exploration of a respiratory distress symptom cluster in lung cancer: Cough, breathlessness and fatigue
|
Molassiotis, A.
|
|
2011
|
71 |
1 |
p. 94-102
9 p.
|
artikel
|
| 7 |
Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC
|
Chang, Alex
|
|
2011
|
71 |
1 |
p. 3-10
8 p.
|
artikel
|
| 8 |
Contents
|
|
|
2011
|
71 |
1 |
p. vii-viii
nvt p.
|
artikel
|
| 9 |
Corrigendum to “Cost-effectiveness analysis of bevacizumab versus pemetrexed for advanced non-squamous NSCLC in Italy” [Lung Cancer 69S1 (2010) S11–S18]
|
Giuliani, Giovanni
|
|
2011
|
71 |
1 |
p. 118-
1 p.
|
artikel
|
| 10 |
Editorial Board
|
|
|
2011
|
71 |
1 |
p. v-
1 p.
|
artikel
|
| 11 |
Health-related quality of life among early-stage, non-small cell, lung cancer survivors
|
Ostroff, Jamie S.
|
|
2011
|
71 |
1 |
p. 103-108
6 p.
|
artikel
|
| 12 |
Histologic features of low- and intermediate-grade neuroendocrine carcinoma (typical and atypical carcinoid tumors) of the lung
|
Tsuta, Koji
|
|
2011
|
71 |
1 |
p. 34-41
8 p.
|
artikel
|
| 13 |
Mutation analysis of the FRK gene in non-small cell lung cancers
|
Jin, Guang
|
|
2011
|
71 |
1 |
p. 115-117
3 p.
|
artikel
|
| 14 |
PI3K/PTEN/AKT/mTOR pathway genetic variation predicts toxicity and distant progression in lung cancer patients receiving platinum-based chemotherapy
|
Pu, Xia
|
|
2011
|
71 |
1 |
p. 82-88
7 p.
|
artikel
|
| 15 |
Predictors of skeletal-related events in non-small cell lung cancer patients with bone metastases
|
Sun, Jong-Mu
|
|
2011
|
71 |
1 |
p. 89-93
5 p.
|
artikel
|
| 16 |
Premature senescence induced by DNA demethylating agent (Decitabine) as therapeutic option for malignant pleural mesothelioma
|
Amatori, S.
|
|
2011
|
71 |
1 |
p. 113-115
3 p.
|
artikel
|
| 17 |
Prognostic value of SUVmax measurements obtained by FDG-PET in patients with non-small cell lung cancer receiving chemotherapy
|
Imamura, Yohei
|
|
2011
|
71 |
1 |
p. 49-54
6 p.
|
artikel
|
| 18 |
Promising efficacy of sorafenib in a relapsed thymic carcinoma with C-KIT exon 11 deletion mutation
|
Dişel, Umut
|
|
2011
|
71 |
1 |
p. 109-112
4 p.
|
artikel
|
| 19 |
Secretoglobin 3A2/uteroglobin-related protein 1 is a novel marker for pulmonary carcinoma in mice and humans
|
Kurotani, Reiko
|
|
2011
|
71 |
1 |
p. 42-48
7 p.
|
artikel
|
| 20 |
Suppression of hydroxyurea-induced centrosome amplification by NORE1A and down-regulation of NORE1A mRNA expression in non-small cell lung carcinoma
|
Shinmura, Kazuya
|
|
2011
|
71 |
1 |
p. 19-27
9 p.
|
artikel
|
| 21 |
Surgery and mesothelioma: If not randomization, at least standardization and registration!
|
Pass, Harvey
|
|
2011
|
71 |
1 |
p. 1-2
2 p.
|
artikel
|
| 22 |
Survival after trimodality therapy for malignant pleural mesothelioma: Radical Pleurectomy, chemotherapy with Cisplatin/Pemetrexed and radiotherapy
|
Bölükbas, Servet
|
|
2011
|
71 |
1 |
p. 75-81
7 p.
|
artikel
|
| 23 |
The function of IGF-IR in NNK-mediated lung tumorigenesis
|
Siwicky, Megan D.
|
|
2011
|
71 |
1 |
p. 11-18
8 p.
|
artikel
|
| 24 |
The safety and efficacy of weekly paclitaxel in combination with carboplatin for advanced non-small cell lung cancer with idiopathic interstitial pneumonias
|
Minegishi, Yuji
|
|
2011
|
71 |
1 |
p. 70-74
5 p.
|
artikel
|
Tijdschrift beschrijving